SK

Susanta Kumar Chhotaray

Active Director Managing Director DIN 09441255
DIN 09441255 First appointment Dec 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Susanta Kumar Chhotaray

Data last updated:

Susanta Kumar Chhotaray is a Managing Director at Drs Rx Pharma Private Limited (since 2021). The company operates in Pharma. Drs Rx Pharma Private Limited reported revenue of ₹1.02 Cr (FY 2025).

DIN 09441255
Primary Designation Managing Director
Industry Pharma
First Appointment 20 Dec 2021
Oldest Company Age 4 yrs
Largest company Drs Rx Pharma Private Limited · ₹1.02 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Drs Rx Pharma Private Limited U51909OR2021PTC038470
Managing Director20 Dec 20212021₹1.02 Cr (FY 2025)Active

Board colleagues of Susanta Kumar Chhotaray

NameDINCompanyDesignation
Rakesh Kumar Pradhan09441256Drs Rx Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Drs Rx Pharma Private Limited
Premium access

Shareholding and investment profile for Susanta Kumar Chhotaray

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Susanta Kumar Chhotaray

Susanta Kumar Chhotaray currently holds 1 directorship: Drs Rx Pharma Private Limited (Managing Director, since 20 Dec 2021, revenue ₹1.02 Cr (FY 2025)).

Susanta Kumar Chhotaray was first appointed on 20 Dec 2021 as Managing Director at Drs Rx Pharma Private Limited.

The current boards of Susanta Kumar Chhotaray's companies include Rakesh Kumar Pradhan (Drs Rx Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available